Spain likely to join AstraZeneca coronavirus vaccine purchase
France, Germany, Italy, the Netherlands also part of deal
Moody’s Analytics Chief Markets Economist John Lonski provides insight into consumer spending amid the coronavirus pandemic, economic recovery and African American unemployment.
Spain is ‘very likely’ to join four other European governments in a deal to buy COVID-19 vaccine from British drugmaker AstraZeneca (AZN.L), Health Emergency Coordinator Fernando Simon said on Monday.
US ECONOMIC RECOVERY HINGES ON LIMITING SPREAD OF CORONAVIRUS, FED'S KAPLAN SAYS
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| AZN | ASTRAZENECA PLC | 63.34 | +0.11 | +0.17% |
The pharmaceutical group agreed on Saturday to supply 400 million doses of its vaccine, which is still under development, to the governments of France, Germany, Italy and the Netherlands.
US FDA REVOKES EMERGENCY USE STATUS OF DRUG TOUTED BY TRUMP FOR COVID-19
Johns Hopkins University Professor of Public Health Dr. Marty Makary provides insight into increasing coronavirus cases as parts of the country reopen.
CLICK HERE TO GET FOX BUSINESS ON THE GO
Speaking at a news conference, Simon said Spain may also join with other countries pursuing different vaccines.